Panstwowy Instytut Medyczny Ministerstwa Spraw Wewnetrznych I Administracji

The department is conducting studies that aim to evaluate new therapeutic options for a range of skin conditions, from inflammatory disorders to rare ulcerative diseases.

• alopecia areata
• atopic dermatitis
• chronic spontaneous urticaria
• hidradenitis suppurativa
• moderate-to-severe plaque psoriasis
• prurigo nodularis
• ulcerative pyoderma gangrenosum
• systemic sclerosis

Researchers at the Panstwowy Instytut Medyczny are testing novel topical and systemic agents to improve symptom control and quality of life for patients with these dermatologic and connective‑tissue disorders.

Trials focus on modulating immune pathways to reduce disease activity in conditions driven by dysregulated immunity.

• chronic spontaneous urticaria
• atopic dermatitis
• moderate-to-severe plaque psoriasis
• hidradenitis suppurativa

The site evaluates innovative biologics and small‑molecule inhibitors to determine whether they can safely suppress the underlying immune activation associated with these diseases.

Research aims to identify treatments that improve lung function and reduce exacerbations in patients with severe airway inflammation.

• inadequately controlled moderate to severe asthma

At the Warsaw clinic, investigators are assessing novel inhaled and systemic agents to see if they can provide better symptom relief and prevent disease progression.

Studies are designed to test interventions that target weight management and glycaemic control, addressing the growing burden of metabolic disorders.

• obesity
• overweight
• type 1 diabetes mellitus
• type 2 diabetes mellitus

The clinical program includes both lifestyle‑based approaches and pharmacologic therapies to determine their effectiveness in reducing disease complications.

The focus is on alleviating painful menstrual symptoms through novel therapeutic agents.

• primary dysmenorrhea

Researchers at the institute are conducting randomized studies to see whether botanical extracts can safely reduce cramping and improve daily functioning for women.

Clinical investigations target inflammatory bowel conditions, seeking therapies that induce remission and sustain mucosal healing.

• ulcerative colitis
• colitis ulcerative
• ulcerative pyoderma gangrenosum

The Warsaw site compares investigational agents with established biologics to evaluate whether patients achieve faster symptom relief and longer periods of disease control.

Although not the primary focus, the department monitors skin‑related infectious conditions to ensure comprehensive patient care.

• assessment of adjunctive therapies for bacterial skin infections
• evaluation of antifungal treatments for chronic dermatomycoses

Ongoing observational studies at the institute help define optimal management strategies for these infections alongside dermatologic research.